• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by John Wiley & Sons Inc. (Amendment)

    2/13/24 5:08:09 PM ET
    $WLY
    Books
    Consumer Discretionary
    Get the next $WLY alert in real time by email
    SC 13G/A 1 tv01256-johnwileysonsincclas.htm SCHEDULE 13G/A johnwileysonsincclassa

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 13)*

    Name of issuer:  John Wiley & Sons, Inc. Class A

    Title of Class of Securities:  Common Stock

    CUSIP Number:  968223206

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  968223206

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    27,142

    7.  SOLE DISPOSITIVE POWER

    5,398,335

    8.  SHARED DISPOSITIVE POWER

    67,876

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    5,466,211

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.92%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    John Wiley & Sons, Inc. Class A

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    111 River Street
    Hoboken, NJ 07030

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    968223206

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $WLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLY

    DatePrice TargetRatingAnalyst
    9/8/2022Market Perform → Market Outperform
    CJS Securities
    8/29/2022Market Outperform → Market Perform
    CJS Securities
    More analyst ratings

    $WLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kissner Matthew S bought $502,028 worth of Class A Common (16,550 units at $30.33), increasing direct ownership by 181% to 25,705 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 6:04:59 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4) (Amendment)

    4/A - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 2:50:35 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/18/23 4:30:50 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Singh Inder M

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:48:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Mcdaniel Raymond W

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:47:08 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Madden Karen N

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:45:44 PM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $WLY
    SEC Filings

    View All

    Wiley upgraded by CJS Securities

    CJS Securities upgraded Wiley from Market Perform to Market Outperform

    9/8/22 9:07:27 AM ET
    $WLY
    Books
    Consumer Discretionary

    Wiley downgraded by CJS Securities

    CJS Securities downgraded Wiley from Market Outperform to Market Perform

    8/29/22 10:00:26 AM ET
    $WLY
    Books
    Consumer Discretionary

    John Wiley & Sons Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/10/25 11:21:47 AM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 10-Q filed by John Wiley & Sons Inc.

    10-Q - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/5/25 9:40:56 AM ET
    $WLY
    Books
    Consumer Discretionary

    John Wiley & Sons Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/4/25 11:00:14 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Financials

    Live finance-specific insights

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    11/8/24 3:02:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/23/24 5:04:46 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/18/24 8:42:58 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Leadership Updates

    Live Leadership Updates

    View All

    Wiley Appoints Katya Andresen to Board of Directors

    Chief Digital & Analytics Officer for The Cigna Group has strong background in technology and AI innovation Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Katya Andresen, chief digital & analytics officer for The Cigna Group, to its Board of Directors. Andresen's background spans technology, data, analytics, and AI innovation across Fortune 500 companies and emerging enterprises. She has led significant initiatives at The Cigna Group and Capital One and successfully transformed Cricket Media by launching a profitable data and digital licensing business. "As we continue to advance our priorities

    6/30/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Appoints Craig Albright as Executive Vice President and Chief Financial Officer

    Seasoned finance executive brings a proven track record in driving profitable growth, improving operational efficiency, and optimizing cash flow Wiley (NYSE:WLY), one of the world's largest publishers and a global leader in research and education, today announced the appointment of Craig Albright as executive vice president and chief financial officer, effective June 26, 2025. Chris Caridi, who has led Wiley's finance organization as interim chief financial officer, will continue with the role of senior vice president, chief accounting officer and finance transformation leader. Albright joins Wiley with over 30 years of global leadership expertise in finance, strategy, and consulting ro

    6/23/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

    MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. At MilliporeSigma, Madden shapes the Technology Roadmap and long-term R&D strategy, systematically exploring emerging opportunities that lead to breakthrough innovations. She leads the Life Science Innovation Board, ensuring a balance o

    3/5/25 8:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary